12,341 Shares in iShares U.S. Pharmaceuticals ETF $IHE Purchased by Strategy Asset Managers LLC

Strategy Asset Managers LLC acquired a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,341 shares of the company’s stock, valued at approximately $1,241,000. Strategy Asset Managers LLC owned about 0.08% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the stock. Sunbelt Securities Inc. boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 14.3% during the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after purchasing an additional 120 shares during the period. Root Financial Partners LLC increased its holdings in iShares U.S. Pharmaceuticals ETF by 36.5% in the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after purchasing an additional 186 shares during the last quarter. Corient Private Wealth LLC raised its position in iShares U.S. Pharmaceuticals ETF by 3.1% in the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after purchasing an additional 198 shares during the period. Cornerstone Wealth Group LLC raised its position in iShares U.S. Pharmaceuticals ETF by 13.7% in the first quarter. Cornerstone Wealth Group LLC now owns 2,847 shares of the company’s stock valued at $246,000 after purchasing an additional 342 shares during the period. Finally, NewEdge Advisors LLC raised its position in iShares U.S. Pharmaceuticals ETF by 45.1% in the first quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock valued at $121,000 after purchasing an additional 434 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 2.2%

NYSEARCA:IHE opened at $99.49 on Thursday. The stock’s fifty day moving average is $102.55 and its two-hundred day moving average is $96.44. iShares U.S. Pharmaceuticals ETF has a 52 week low of $73.42 and a 52 week high of $108.66. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.